These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24483484)

  • 21. Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
    Asbach B; Kibler KV; Köstler J; Perdiguero B; Yates NL; Stanfield-Oakley S; Tomaras GD; Kao SF; Foulds KE; Roederer M; Seaman MS; Montefiori DC; Parks R; Ferrari G; Forthal DN; Phogat S; Tartaglia J; Barnett SW; Self SG; Gottardo R; Cristillo AD; Weiss DE; Galmin L; Ding S; Heeney JL; Esteban M; Jacobs BL; Pantaleo G; Wagner R
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conservation and variability of dengue virus proteins: implications for vaccine design.
    Khan AM; Miotto O; Nascimento EJ; Srinivasan KN; Heiny AT; Zhang GL; Marques ET; Tan TW; Brusic V; Salmon J; August JT
    PLoS Negl Trop Dis; 2008 Aug; 2(8):e272. PubMed ID: 18698358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune Modulation of NYVAC-Based HIV Vaccines by Combined Deletion of Viral Genes that Act on Several Signalling Pathways.
    Gómez CE; Perdiguero B; Sánchez-Corzo C; Sorzano COS; Esteban M
    Viruses; 2017 Dec; 10(1):. PubMed ID: 29280955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
    Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
    J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Realistic three dimensional fitness landscapes generated by self organizing maps for the analysis of experimental HIV-1 evolution.
    Lorenzo-Redondo R; Delgado S; Morán F; Lopez-Galindez C
    PLoS One; 2014; 9(2):e88579. PubMed ID: 24586344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1-specific CD8+ T cell responses and viral evolution in women and infants.
    Sanchez-Merino V; Nie S; Luzuriaga K
    J Immunol; 2005 Nov; 175(10):6976-86. PubMed ID: 16272358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 mutates to adapt in fluxing environments.
    Nomaguchi M; Doi N; Koma T; Adachi A
    Microbes Infect; 2018; 20(9-10):610-614. PubMed ID: 28859896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.
    Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Das BK; Kabra SK; Lodha R; Luthra K
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissecting the dynamics of HIV-1 protein sequence diversity.
    Hu Y; Tan PT; Tan TW; August JT; Khan AM
    PLoS One; 2013; 8(4):e59994. PubMed ID: 23593157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing broadly reactive HIV-1/AIDS vaccines: a review of polyvalent and centralized HIV-1 vaccines.
    McBurney SP; Ross TM
    Curr Pharm Des; 2007; 13(19):1957-64. PubMed ID: 17627529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reconstruction and function of ancestral center-of-tree human immunodeficiency virus type 1 proteins.
    Rolland M; Jensen MA; Nickle DC; Yan J; Learn GH; Heath L; Weiner D; Mullins JI
    J Virol; 2007 Aug; 81(16):8507-14. PubMed ID: 17537854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inferring the intrinsic mutational fitness landscape of influenzalike evolving antigens from temporally ordered sequence data.
    Doelger J; Kardar M; Chakraborty AK
    Phys Rev E; 2022 Feb; 105(2-1):024401. PubMed ID: 35291059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
    Brumme ZL; Brumme CJ; Heckerman D; Korber BT; Daniels M; Carlson J; Kadie C; Bhattacharya T; Chui C; Szinger J; Mo T; Hogg RS; Montaner JS; Frahm N; Brander C; Walker BD; Harrigan PR
    PLoS Pathog; 2007 Jul; 3(7):e94. PubMed ID: 17616974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.
    Brockman MA; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Altfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM
    J Virol; 2010 Nov; 84(22):11937-49. PubMed ID: 20810731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 replicative fitness in elite controllers.
    Lobritz MA; Lassen KG; Arts EJ
    Curr Opin HIV AIDS; 2011 May; 6(3):214-20. PubMed ID: 21430530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome.
    Ranasinghe S; Flanders M; Cutler S; Soghoian DZ; Ghebremichael M; Davis I; Lindqvist M; Pereyra F; Walker BD; Heckerman D; Streeck H
    J Virol; 2012 Jan; 86(1):277-83. PubMed ID: 22031937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.
    Troyer RM; McNevin J; Liu Y; Zhang SC; Krizan RW; Abraha A; Tebit DM; Zhao H; Avila S; Lobritz MA; McElrath MJ; Le Gall S; Mullins JI; Arts EJ
    PLoS Pathog; 2009 Apr; 5(4):e1000365. PubMed ID: 19343217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges in the development of an HIV-1 vaccine.
    Barouch DH
    Nature; 2008 Oct; 455(7213):613-9. PubMed ID: 18833271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity.
    Rolland M; Manocheewa S; Swain JV; Lanxon-Cookson EC; Kim M; Westfall DH; Larsen BB; Gilbert PB; Mullins JI
    J Virol; 2013 May; 87(10):5461-7. PubMed ID: 23468488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV type 1 vaccines for worldwide use: predicting in-clade and cross-clade breadth of immune responses.
    Finnefrock AC; Liu X; Opalka DW; Shiver JW; Casimiro DR; Condra JH
    AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1283-92. PubMed ID: 17961117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.